ENDRA Life Sciences (NDRA) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free NDRA Stock Alerts $0.27 -0.01 (-3.61%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ENDRA Life Sciences Short Interest DataCurrent Short Interest104,700 sharesPrevious Short Interest4,000 sharesChange Vs. Previous Month+2,517.50%Dollar Volume Sold Short$30,415.35Short Interest Ratio0.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares11,040,000 sharesFloat Size10,880,000 sharesShort Percent of Float0.96%Today's Trading Volume22,739 sharesAverage Trading Volume114,239 sharesToday's Volume Vs. Average20% Short Selling ENDRA Life Sciences ? Sign up to receive the latest short interest report for ENDRA Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNDRA Short Interest Over TimeNDRA Days to Cover Over TimeNDRA Percentage of Float Shorted Over Time Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ENDRA Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024104,700 shares $30,415.35 +2,517.5%1.0%0.6 $0.29 4/30/20244,000 shares $1,131.60 -47.4%0.0%0 $0.28 4/15/20247,600 shares $1,991.20 -75.2%0.1%0 $0.26 3/31/202430,600 shares $17,748.00 -36.9%0.3%0.2 $0.58 3/15/202448,500 shares $48,500.00 -11.3%0.5%0.3 $1.00 2/29/202454,700 shares $61,264.00 +86.1%0.5%0.4 $1.12 Get the Latest News and Ratings for NDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202429,400 shares $33,810.00 +47.7%0.4%0.3 $1.15 1/31/202419,900 shares $20,895.00 -73.7%0.2%0.2 $1.05 1/15/202475,700 shares $98,410.00 -41.8%0.9%0.8 $1.30 12/31/2023130,000 shares $275,600.00 -25.5%1.6%1.4 $2.12 12/15/2023174,500 shares $251,280.00 -17.3%2.1%2.3 $1.44 11/30/2023211,100 shares $206,434.69 -11.8%2.6%1.9 $0.98 11/15/2023239,300 shares $227,335.00 -6.1%2.9%2.4 $0.95 10/31/2023254,900 shares $251,076.50 +56.5%3.5%2.2 $0.99 10/15/2023162,900 shares $169,416.00 +28.9%2.2%1.4 $1.04 9/30/2023126,400 shares $140,316.64 +175.4%1.7%1.1 $1.11 9/15/202345,900 shares $56,457.00 -37.1%0.6%0.4 $1.23 8/31/202373,000 shares $85,410.00 +5.5%1.0%1.2 $1.17 8/15/202369,200 shares $79,580.00 +61.7%0.9%1.1 $1.15 7/31/202342,800 shares $53,072.00 -20.0%0.6%0.8 $1.24 7/15/202353,500 shares $72,760.00 -36.5%0.7%0.8 $1.36 6/30/202384,300 shares $118,020.00 +13.2%1.2%1.3 $1.40 6/15/202374,500 shares $109,515.00 +40.0%1.0%1.4 $1.47 5/31/202353,200 shares $78,204.00 +54.7%0.8%1.2 $1.47 5/15/202334,400 shares $44,032.00 -70.1%0.5%1 $1.28 4/30/2023114,900 shares $183,840.00 +61.2%1.9%3.9 $1.60 4/15/202371,300 shares $131,905.00 +124.2%2.4%5.7 $1.85 3/31/202331,800 shares $72,818.82 -7.8%1.1%2.6 $2.29 3/15/202334,500 shares $124,200.00 +24.1%1.2%2.6 $3.60 2/28/202327,800 shares $108,420.00 -7.6%0.9%1.3 $3.90 2/15/202330,100 shares $111,370.00 -9.1%1.0%1.4 $3.70 1/31/202333,100 shares $132,731.00 -23.2%1.1%1.4 $4.01 1/15/202343,100 shares $202,570.00 +28.3%1.4%1.8 $4.70 12/30/202233,600 shares $136,752.00 -54.4%1.1%1.4 $4.07 12/15/202273,600 shares $374,624.00 +173.6%2.4%3.2 $5.09 11/30/202226,900 shares $4,777.44 -95.5%0.9%2 $0.18 11/15/2022597,800 shares $119,679.56 +8.8%N/A2.2 $0.20 10/31/2022549,600 shares $126,408.00 -19.7%N/A1.9 $0.23 10/15/2022684,800 shares $208,521.60 -11.7%N/A2.1 $0.30 9/30/2022775,300 shares $237,241.80 +0.1%N/A2.1 $0.31Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here 9/15/2022774,500 shares $278,820.00 +11.5%N/A1.9 $0.36 8/31/2022694,700 shares $202,643.99 -8.8%N/A1.5 $0.29 8/15/2022761,900 shares $275,045.90 +17.1%N/A1.3 $0.36 7/31/2022650,600 shares $178,784.88 -6.2%N/A0.8 $0.27 7/15/2022693,400 shares $163,919.76 -17.9%N/A0.6 $0.24 6/30/2022844,400 shares $196,745.20 +97.2%N/A0.3 $0.23 6/15/2022428,200 shares $102,768.00 -55.0%N/A0.1 $0.24 5/31/2022952,400 shares $219,052.00 +282.3%N/A0.3 $0.23 5/15/2022249,100 shares $49,570.90 -86.9%N/A0.1 $0.20 4/30/20221,900,000 shares $492,860.00 -12.0%N/A0.8 $0.26 4/15/20222,160,000 shares $559,440.00 +285.8%N/A0.9 $0.26 3/31/2022559,900 shares $218,361.00 +30.2%N/A0.4 $0.39 3/15/2022430,200 shares $167,778.00 +32.1%1.1%1.6 $0.39 2/28/2022325,600 shares $139,356.80 -11.2%0.8%1.2 $0.43 2/15/2022366,500 shares $160,893.50 +16.8%0.9%1.2 $0.44 1/31/2022313,900 shares $188,340.00 -38.4%0.8%1 $0.60 1/15/2022509,300 shares $352,944.90 -1.4%1.2%1.6 $0.69 12/31/2021516,400 shares $357,245.52 +5.2%1.3%1.7 $0.69 12/15/2021491,000 shares $374,142.00 -11.9%1.2%1.8 $0.76 11/30/2021557,200 shares $530,510.12 -45.4%1.4%2.2 $0.95 11/15/20211,020,000 shares $1.36 million -15.0%2.5%4 $1.33 10/29/20211,200,000 shares $1.90 million +9.1%2.9%4.4 $1.58 10/15/20211,100,000 shares $1.74 million -10.6%2.7%4.2 $1.58 9/30/20211,230,000 shares $2.13 million +0.8%3.0%4.2 $1.73 9/15/20211,220,000 shares $2.12 million +1.7%3.0%3.5 $1.74 8/31/20211,200,000 shares $2.28 million +53.4%2.9%3.1 $1.90 8/13/2021782,100 shares $1.27 million -27.6%1.9%1.9 $1.62 7/30/20211,080,000 shares $1.94 million +30.6%2.7%2.5 $1.80 7/15/2021827,100 shares $1.55 million +7.9%2.0%1.5 $1.87 6/30/2021766,800 shares $1.67 million -4.1%1.9%1.2 $2.18 6/15/2021799,200 shares $1.71 million +28.2%2.0%1 $2.14 5/28/2021623,400 shares $1.32 million -46.3%1.5%0.6 $2.12 5/14/20211,160,000 shares $2.30 million -10.8%N/A0.8 $1.98 4/30/20211,300,000 shares $3.21 million -3.7%N/A0.7 $2.47 4/15/20211,350,000 shares $3.08 million +13.5%N/A0.6 $2.28 3/31/20211,190,000 shares $3.06 million +304.4%N/A0.4 $2.57 3/15/2021294,300 shares $735,750.00 -34.1%N/A0.1 $2.50 2/26/2021446,800 shares $1.10 million +19.6%N/A0.2 $2.46 2/12/2021373,700 shares $852,036.00 -61.8%N/A0.1 $2.28 1/29/2021979,400 shares $1.97 million +98.2%N/A0.4 $2.01 1/15/2021494,200 shares $499,142.00 +3.6%N/A0.3 $1.01 12/31/2020476,900 shares $355,290.50 -11.2%N/A0.9 $0.75 12/15/2020537,300 shares $482,925.24 -2.2%N/A1.7 $0.90 11/30/2020549,600 shares $467,434.80 +5.1%N/A3.2 $0.85 11/15/2020522,900 shares $441,327.60 -12.7%N/A3.7 $0.84 10/30/2020598,900 shares $430,070.09 +3.5%N/A4 $0.72 10/15/2020578,800 shares $421,655.80 +0.2%N/A2.6 $0.73 9/30/2020577,800 shares $422,660.70 -1.9%N/A1.9 $0.73 9/15/2020588,800 shares $471,040.00 -1.2%N/A1.4 $0.80 8/31/2020595,700 shares $488,474.00 -2.6%N/A1.2 $0.82Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here 8/14/2020611,300 shares $562,396.00 +7.8%N/A1.2 $0.92 7/31/2020567,200 shares $558,692.00 -1.2%N/A1.1 $0.99 7/15/2020573,900 shares $511,230.12 +2.6%N/A1.1 $0.89 6/30/2020559,600 shares $570,792.00 -9.8%N/A1.4 $1.02 6/15/2020620,400 shares $536,708.04 +0.1%N/A2.1 $0.87 5/29/2020619,700 shares $570,124.00 -0.2%N/A2.7 $0.92 5/15/2020620,800 shares $444,058.24 -3.6%N/A3.4 $0.72 4/30/2020643,700 shares $499,511.20 +1.9%N/A4.4 $0.78 4/15/2020631,700 shares $553,116.52 +0.9%N/A6.8 $0.88 3/31/2020626,100 shares $525,924.00 -0.2%N/A5.5 $0.84 3/13/2020627,200 shares $439,040.00 -5.7%N/A4.9 $0.70 2/28/2020664,800 shares $518,544.00 +1.2%N/A4.6 $0.78 2/14/2020657,000 shares $676,710.00 +13.2%N/A4.6 $1.03 1/31/2020580,300 shares $702,163.00 -13.3%N/A4 $1.21 1/15/2020669,000 shares $929,910.00 -5.9%N/A4.8 $1.39 12/31/2019710,800 shares $1.22 million +2.9%10.0%5.7 $1.71 NDRA Short Interest - Frequently Asked Questions What is ENDRA Life Sciences' current short interest? Short interest is the volume of ENDRA Life Sciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 104,700 shares of NDRA short. 0.96% of ENDRA Life Sciences' shares are currently sold short. Learn More on ENDRA Life Sciences' current short interest. What is a good short interest ratio for ENDRA Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NDRA shares currently have a short interest ratio of 1.0. Learn More on ENDRA Life Sciences's short interest ratio. What is a good short interest percentage for ENDRA Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.96% of ENDRA Life Sciences' floating shares are currently sold short. Is ENDRA Life Sciences' short interest increasing or decreasing? ENDRA Life Sciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 104,700 shares, an increase of 2,517.5% from the previous total of 4,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ENDRA Life Sciences' float size? ENDRA Life Sciences currently has issued a total of 11,040,000 shares. Some of ENDRA Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ENDRA Life Sciences currently has a public float of 10,880,000 shares. How does ENDRA Life Sciences' short interest compare to its competitors? 0.96% of ENDRA Life Sciences' shares are currently sold short. Here is how the short interest of companies compare to ENDRA Life Sciences: Nexalin Technology, Inc. (1.24%), Nuwellis, Inc. (9.00%), Helius Medical Technologies, Inc. (2.66%), Tivic Health Systems, Inc. (1.85%), Medtronic plc (1.15%), Masimo Co. (6.29%), TransMedics Group, Inc. (16.09%), Integer Holdings Co. (8.90%), LivaNova PLC (5.06%), CONMED Co. (11.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short ENDRA Life Sciences stock? Short selling NDRA is an investing strategy that aims to generate trading profit from ENDRA Life Sciences as its price is falling. NDRA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ENDRA Life Sciences? A short squeeze for ENDRA Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NDRA, which in turn drives the price of the stock up even further. How often is ENDRA Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NDRA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NXL Short Interest NUWE Short Interest HSDT Short Interest TIVC Short Interest MDT Short Interest MASI Short Interest TMDX Short Interest ITGR Short Interest LIVN Short Interest CNMD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NDRA) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyWrite this ticker symbol down…StocksToTradeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWho are Nvidia’s New Silent Partners?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
